FRM
Fox Run Management’s Pacira BioSciences PCRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Sell |
-8,963
| Closed | -$366K | – | 891 |
|
2023
Q1 | $366K | Sell |
8,963
-7,987
| -47% | -$326K | 0.12% | 340 |
|
2022
Q4 | $654K | Buy |
+16,950
| New | +$654K | 0.26% | 90 |
|
2019
Q3 | – | Sell |
-9,078
| Closed | -$395K | – | 514 |
|
2019
Q2 | $395K | Buy |
9,078
+237
| +3% | +$10.3K | 0.26% | 134 |
|
2019
Q1 | $336K | Buy |
+8,841
| New | +$336K | 0.19% | 233 |
|
2016
Q4 | – | Sell |
-13,400
| Closed | -$459K | – | 629 |
|
2016
Q3 | $459K | Buy |
13,400
+100
| +0.8% | +$3.43K | 0.27% | 127 |
|
2016
Q2 | $449K | Buy |
+13,300
| New | +$449K | 0.22% | 153 |
|